Zoetis Inc
Fermé
SecteurSoins de santé
78.07 1.63
Résumé
Variation du prix de l'action
24h
Min
76.41
Max
79.02
Revenu | -2M 601M |
|---|---|
Ventes | -125M 2.3B |
P/E Moyenne du Secteur | 12.441 50.958 |
BPA | 1.42 |
Rendement du dividende | 2.58 |
Marge bénéficiaire | 26.569 |
Employés | 14,500 |
EBITDA | -8M 939M |
Recommandations | Achat |
|---|---|
Prévisions sur 12 Mois | +52.29% upside |
Rendement du dividende Moyenne du Secteur | 2.58% 2.41% |
|---|---|
Prochains Résultats | 4 août 2026 |
Date du Prochain Dividende | 1 sept. 2026 |
Date du Prochain Détachement de Dividende | 20 juil. 2026 |
Capitalisation Boursière | -16B 32B |
|---|---|
Ouverture précédente | 76.44 |
Clôture précédente | 78.07 |
Sentiment de l'Actualité
By Acuity
56%
44%
275 / 342 Classement par Healthcare
Zoetis Inc Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
À Propos Zoetis Inc
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.